Kaléo designs and manufactures drug‑device combination products, specializing in auto‑injector platforms that deliver medications safely and efficiently across a range of disease areas and emergency scenarios. Its Aerio™ Auto‑Injector Platform incorporates human‑factors engineering, extensive patent protection, and fully automated production to create precise, user‑friendly delivery systems for pharmaceutical partners, governments, and medical countermeasure programs.
Funding
Funding not disclosed
Founders
Product
Problem
Patients and caregivers often struggle with administering injectable medications safely and comfortably, especially in urgent or emergency situations where rapid, reliable delivery is critical. Traditional injection devices can be complex, error‑prone, and lack adaptability across different therapeutic areas.
Solution
Kaléo offers the Aerio™ auto‑injector platform, a drug‑device combination solution that integrates human‑factors engineering, extensive patent protection, and fully automated manufacturing to produce precise, reliable injection devices. The platform is designed to be flexible, supporting a wide range of disease categories and environments, from routine chronic therapies to emergency countermeasures such as nerve‑agent antidotes. Kaléo works with pharmaceutical companies and government agencies to co‑develop custom‑designed auto‑injectors that ensure medications are delivered comfortably, safely, and efficiently. By combining automated production with rigorous usability testing, the company delivers devices that can be trusted for both everyday use and high‑stakes emergency scenarios.
Target Audience
Primary customers are pharmaceutical manufacturers and government agencies seeking custom, reliable auto‑injector solutions for therapeutic products and emergency medical countermeasures.
Features
- Human‑factors engineering ensures intuitive operation for patients, parents, and caregivers, reducing administration errors
- Approximately 155 issued or pending patents protect the platform’s unique mechanisms and delivery technologies
- Fully automated manufacturing enables high‑volume production while maintaining consistent device performance and quality
- Modular design accommodates diverse drug formulations and therapeutic indications, from chronic treatments to rapid‑response medical countermeasures
- Integrated safety features such as needle‑shielding and dose‑confirmation indicators enhance user confidence and compliance
- Compatibility with regulatory requirements for both commercial pharmaceuticals and government‑issued emergency medicines